Works matching IS 02533766 AND DT 2022 AND VI 44 AND IP 9

Results: 15

化疗诱导的周围神经病变诊治中国专家共识 (2022 版).

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 928, doi. 10.3760/cma.j.cn112152-20220213-00099
Publication type:: Article

中国农村地区肝癌初筛方案效果评价.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 990, doi. 10.3760/cma.j.cn112152-20211031-00800

By:

曹毛毛;
李贺;
查震球;
周金意;
罗鹏飞;
龚继勇;
马恒敏;
孙喜斌;
陈万青

Publication type:

Article

儿童肺黏液表皮样癌6例.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 987, doi. 10.3760/cma.j.cn112152-20200917-00830

By:

汪凤华;
梁建华;
李乐;
王会;
唐决;
曾嘉航;
刘威

Publication type:

Article

CT 采集和重建参数对纯磨玻璃密度肺结节影像组学特征稳定性的影响.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 981, doi. 10.3760/cma.j.cn112152-20201127-01024

By:

杨守鑫;
吴宁;
张丽;
李蒙

Publication type:

Article

衍生的中性粒细胞淋巴细胞比值和肺免疫预后指数对非手术老年非小细胞肺癌患者预后的影响.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 975, doi. 10.3760/cma.j.cn112152-20200423-00371

By:

谢剑华;
刘苗苗;
孙宁宁;
张利;
张洪珍

Publication type:

Article

circTNPO1通过下调miR－338－3p的表达促进骨肉瘤增殖迁移.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 968, doi. 10.3760/cma.j.cn112152-20200529-00496

By:

陆建红;
黄晓文;
张国强;
马彦;
陈君鑫

Publication type:

Article

肿瘤转移相关基因1对宫颈癌HeLa细胞放疗敏感性的作用及机制.

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 962, doi. 10.3760/cma.j.cn112152-20200929-00866
Publication type:: Article

1990—2019 年亚洲主要国家胰腺癌疾病负担和归因风险因素及相关预测分析.

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 955, doi. 10.3760/cma.j.cn112152-20211027-00790
Publication type:: Article

1990—2019 年全球胃癌发病率和死亡率变化趋势及地区差异.

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 950, doi. 10.3760/cma.j.cn112152-20220120-00049
Publication type:: Article

中国恶性肿瘤一级预防现状与展望.

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 942, doi. 10.3760/cma.j.cn112152-20220209-00083
Publication type:: Article

免疫检查点抑制剂相关神经不良反应诊治中国专家共识 (2022 版).

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 935, doi. 10.3760/cma.j.cn112152-20220213-00098
Publication type:: Article

中国乳腺癌抗体药物偶联物安全性管理专家共识.

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 913, doi. 10.3760/cma.j.cn112152-20220521-00360
Publication type:: Article

中国黑色素瘤规范诊疗质量控制指标 (2022 版).

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 908, doi. 10.3760/cma.j.cn112152-20220707-00479
Publication type:: Article

中国甲状腺癌规范诊疗质量控制指标 (2022 版).

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 902, doi. 10.3760/cma.j.cn112152-20220707-00477
Publication type:: Article

中国鼻咽癌规范诊疗质量控制指标(2022版).

Published in:: Chinese Journal of Oncology, 2022, v. 44, n. 9, p. 895, doi. 10.3760/cma.j.cn112152-20220707-00478
Publication type:: Article